Arterial stiffness in chronic inflammatory diseases

Mary J Roman1, Richard B Devereux, Joseph E Schwartz

  • 1Division of Cardiology, Weill Medical College, Cornell University, 525 East 68th St, New York, NY 10021, USA. mroman@med.cornell.edu

Insights

Chronic inflammatory diseases increase arterial stiffness, a sign of vascular disease, independent of atherosclerosis. This stiffness is linked to disease duration, cholesterol, and inflammatory markers like C-reactive protein and IL-6.

Area of Science:

  • Cardiovascular Medicine
  • Rheumatology
  • Vascular Biology

Background:

  • Chronic inflammatory diseases are linked to premature atherosclerosis.
  • The role of arterial stiffness in these conditions, independent of atherosclerosis, remains unclear.

Purpose of the Study:

  • To investigate arterial stiffness in patients with systemic lupus erythematosus and rheumatoid arthritis compared to healthy controls.
  • To determine if increased arterial stiffness is present independently of atherosclerosis in chronic inflammatory diseases.

Main Methods:

  • Carotid ultrasonography and radial applanation tonometry were used in 101 lupus patients, 80 rheumatoid arthritis patients, and 105 controls.
  • Arterial stiffness was assessed using beta, Young's modulus, and Peterson's elastic modulus.
  • Multivariate analyses were performed to identify independent predictors of arterial stiffness.

Main Results:

  • Patients with lupus and rheumatoid arthritis had significantly increased arterial stiffness compared to controls, even after adjusting for blood pressure.
  • Atherosclerotic plaque was more prevalent in patient groups.
  • Arterial stiffness was independently related to age, serum glucose, and chronic inflammatory disease presence in the overall population.
  • In patients, stiffness correlated with age at diagnosis, disease duration, cholesterol, C-reactive protein (CRP), and IL-6.
  • Increased arterial stiffness persisted in patients without carotid plaque.

Conclusions:

  • Arterial stiffness is elevated in chronic inflammatory disorders, independent of atherosclerosis.
  • Disease duration, cholesterol levels, and inflammatory markers (CRP, IL-6) are associated with increased arterial stiffness in these patients.

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...